ARCHIVES

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer”

May 1, 1992

Dexamethasone Improved Survival Of Leukemia

November 26, 2004

NAS Report Advises Candidates on Filling Key Science Positions.

October 31, 2008

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Robert Cook-Deegan On Implications of Appelate Court Ruling In Myriad Case Ruling

August 5, 2011

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012